Our study confirms the highly significant effect of no-reflow on the course and perioperative death rate in ACS and COVID-19(+) patients.
← all excerpts
The Most Relevant Factors Affecting the Perioperative Death Rate in Patients with Acute Coronary Syndrome and COVID-19, Based on Annual Follow-Up in the ORPKI Registry.
1
—
—